What they are losing is estrogen, which affects the brain wiring responsible for memory and how fast you process information.
A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...
The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously ...
There is growing momentum to legalize certain psychedelics — namely psilocybin. That push is well underway in Nevada.
Inquirer on MSN5d
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...
UXDA applies neuromarketing in banking to reshape the way people interact with their financial services. Our developed ...
Alcohol has long been synonymous with relaxation. If you want to unwind after a rough day at work—or kick back on the couch, ...
MDMA primarily affects the neurotransmitter in the brain including serotonin, dopamine, and norepinephrine: Serotonin: Releases feelings of heightened mood, emotional bonding, and empathy. Dopamine: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback